RepliCel Life Sciences (TSE:RP) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RepliCel Life Sciences has rescheduled its annual meeting to January 16, 2025, where shareholders will vote on the sale of assets and delisting from the TSX Venture Exchange. The company also announced the resignation of board member Jamie Mackay, who played a crucial role in maintaining company operations during challenging times.
For further insights into TSE:RP stock, check out TipRanks’ Stock Analysis page.